ストックスクリーナーアプリを入手
0.95
10.72%
0.092
アフターアワーズ：
.97
0.02
+2.11%
前日終値:
$0.858
開ける：
$0.85
24時間の取引高:
203.87K
Relative Volume:
2.29
時価総額：
$29.49M
収益：
$8.59M
当期純損益:
$-17.07M
株価収益率:
-0.6169
EPS:
-1.54
ネットキャッシュフロー:
$-21.90M
1週間 パフォーマンス:
+26.67%
1か月 パフォーマンス:
+5.14%
6か月 パフォーマンス:
-36.24%
1年 パフォーマンス:
+89.24%
1日の値動き範囲:
$0.81
$1.022
1週間の範囲:
$0.7362
$1.022
52週間の値動き範囲:
$0.4938
$1.88
Durect Corp Stock (DRRX) Company Profile
DRRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DRRX
Durect Corp
|
0.95 | 29.49M | 8.59M | -17.07M | -21.90M | -0.61 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Durect Corp Stock (DRRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-10-30 | 開始されました | Chardan Capital Markets | Buy |
| 2020-10-12 | 開始されました | ROTH Capital | Buy |
| 2020-07-31 | 開始されました | Oppenheimer | Outperform |
| 2020-01-31 | 開始されました | B. Riley FBR | Buy |
| 2019-11-18 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-09-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-03-06 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2017-10-20 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2017-10-20 | 繰り返されました | Laidlaw | Buy |
| 2017-10-20 | ダウングレード | Stifel | Buy → Hold |
| 2017-07-12 | アップグレード | Stifel | Hold → Buy |
| 2017-02-28 | 再開されました | H.C. Wainwright | Buy |
| 2016-04-25 | 開始されました | Rodman & Renshaw | Buy |
| 2015-05-01 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2015-05-01 | 繰り返されました | Stifel | Buy |
| 2013-03-25 | 開始されました | Stifel | Buy |
| 2012-11-01 | ダウングレード | C.K. Cooper | Buy → Hold |
| 2012-08-17 | 開始されました | C.K. Cooper | Buy |
| 2009-06-23 | 開始されました | Caris & Company | Buy |
| 2009-03-26 | 開始されました | Wedbush Morgan | Hold |
すべてを表示
Durect Corp (DRRX) 最新ニュース
Durect (DRRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
DURECT Corp expected to post a loss of 17 cents a shareEarnings Preview - XM
Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
DURECT Corp sells ALZET product line to Lafayette - TradingPedia
Durect announces sale of Alzet line of osmotic pumps to LIC for $17.5M - TipRanks
DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million - PR Newswire
DURECT Corporation (NASDAQ:DRRX) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: DURECT Corporation reports Q3 2024 financials - Investing.com
Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ... - Yahoo Finance
Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Gro - GuruFocus.com
Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ... By GuruFocus - Investing.com Canada
Durect: Q3 Earnings Snapshot - Houston Chronicle
Durect Corp Q3 2024 Earnings: GAAP EPS of -$0.14 Misses Estimates, Revenue at $1.9 Million Below Expectations - GuruFocus.com
Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Durect reports Q3 EPS (14c), consensus (17c) - TipRanks
DURECT Q3: $4.3M Loss, Plans Phase 3 Trial Amid Funding Needs & License Agreement End | DRRX Stock News - StockTitan
DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update - PR Newswire
DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update - StockTitan
DRRXDurect Corp Latest Stock News & Market Updates - StockTitan
DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024 - StockTitan
Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Gro - GuruFocus.com
Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Advances Amid ... - Yahoo Finance
Durect Corp Annual Meeting Decisions and Shareholder Votes - TipRanks
H.C. Wainwright maintains Neutral rating on Durect shares post FDA meeting - Investing.com
DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis - PR Newswire
DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference - PR Newswire
Durect Corp (NQ: DRRX - Financial Content
Durect (FRA:DC8A) Total Inventories : €2.30 Mil (As of Jun. 2024) - GuruFocus.com
DURECT Co. (NASDAQ:DRRX) Expected to Post Q3 2024 Earnings of ($0.14) Per Share - Defense World
HC Wainwright Analysts Reduce Earnings Estimates for DURECT Co. (NASDAQ:DRRX) - Defense World
DURECT Corporation (NASDAQ:DRRX) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: DURECT Corp reports steady Q2 financials, plans Phase III trial - Investing.com India
Durect: Q2 Earnings Snapshot - Houston Chronicle
Durect (DRRX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update - PR Newswire
DURECT (DRRX) Set to Announce Quarterly Earnings on Tuesday - Defense World
DURECT Co. (NASDAQ:DRRX) Receives $27.50 Average Target Price from Brokerages - American Banking and Market News
DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update - StockTitan
ProAssurance Co. (NYSE:PRA) Shares Bought by CANADA LIFE ASSURANCE Co - Defense World
DURECT (DRRX) Stock Price, News & Analysis - MarketBeat
Altair Engineering (NASDAQ:ALTR) Stock Rating Lowered by The Goldman Sachs Group - Defense World
DURECT (NASDAQ:DRRX) Stock Price Passes Above Two Hundred Day Moving Average of $1.13 - MarketBeat
DURECT Co. (NASDAQ:DRRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
DURECT (NASDAQ:DRRX) Stock Price Passes Above 200-Day Moving Average of $1.01 - Defense World
Durect - The Pharma Letter
DURECT Corporation Announces Presentations in Upcoming Investor Conferences - Quantisnow
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update - Quantisnow
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update - Quantisnow
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Quantisnow
DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol ... - Quantisnow
DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update - Quantisnow
Durect Corp (DRRX) 財務データ
収益
当期純利益
現金流量
EPS
1.61%
1.65%
大文字化:
|
ボリューム (24 時間):